New data show patients’ out-of-pocket costs are rising faster than their insurers’ costs
New data from the Kaiser Family Foundation show patient out-of-pocket costs rose faster than the costs paid by their insurers between 2006 and 2016.
New data from the Kaiser Family Foundation show patient out-of-pocket costs rose faster than the costs paid by their insurers between 2006 and 2016.
Newly released data from the Kaiser Family Foundation show out-of-pocket costs for patients with employer-sponsored health insurance rose faster than the costs paid by their insurers between 2006 and 2016. Over this decade, the total amount patients spent out of pocket grew, on average, from $525 to $806. That increase of 54 percent is higher than the increase in payments by health insurers, which rose 48 percent, on average, over the same time period (from $3,182 to $4,724).
In addition, from 2006 to 2016:
As patient out-of-pocket costs increase dramatically and cost-sharing shifts from fixed copays to less predictable deductibles and coinsurance, patients will continue to face affordability challenges. Even though rebates paid by biopharmaceutical companies often substantially reduce what insurers and pharmacy benefit managers (PBMs) pay for medicines, insurers typically use list prices—rather than discounted prices—to determine how much to charge patients with deductibles and coinsurance. In 2017, more than half of patient out-of-pocket spending for brand medicines was for prescriptions filled in the deductible or with coinsurance. No patient should pay more for their medicine than their insurer.
Learn more at LetsTalkAboutCost.org.